Lauren A. Byers

The University of Texas MD Anderson Cancer Center

Biochemistry, Genetics and Molecular BiologyMedicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 67 papers. Top paper: “Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial”.

Neoadjuvant chemotherapy plus nivolumab with or without ipilimumab in operable non-small cell lung cancer: the phase 2 platform NEOSTAR trial

Nature Medicine(2023)10.1038/s41591-022-02189-0

N/A

4.1DataRank · unranked

213 citations

Cheuk Hong Leung, Annikka Weissferdt, Apar Pataer, Brett W. Carter, Myrna C. B. Godoy +52 more

Poziotinib for EGFR exon 20-mutant NSCLC: Clinical efficacy, resistance mechanisms, and impact of insertion location on drug sensitivity

Cancer Cell(2022)10.1016/j.ccell.2022.06.006

N/A

3.9DataRank · unranked

106 citations

Jacqulyne Robichaux, Brett W. Carter, Mehmet Altan, Hai T. Tran, Don L. Gibbons +22 more

Molecular classification and biomarkers of outcome with immunotherapy in extensive-stage small-cell lung cancer: analyses of the CASPIAN phase 3 study

Molecular Cancer(2024)10.1186/s12943-024-02014-x

N/A

0.975DataRank · unranked

43 citations

Miljenka Vuko, Jaime Rodriguez‐Canales, Johannes Zimmermann, Markus Schick, Cathy O’Brien +13 more

Rationale and Design of the Phase 3 KEYLYNK-013 Study of Pembrolizumab With Concurrent Chemoradiotherapy Followed by Pembrolizumab With or Without Olaparib for Limited-Stage Small-Cell Lung Cancer

Clinical Lung Cancer(2022)10.1016/j.cllc.2022.04.005

N/A

0.489DataRank · unranked

14 citations

W. Victoria Lai, Raffaele Califano, Salma K. Jabbour, Charles M. Rudin, Corinne Faivre‐Finn +8 more

Distinct patterns of auto-reactive antibodies associated with organ-specific immune-related adverse events

Frontiers in Immunology(2023)10.3389/fimmu.2023.1322818

N/A

0.357DataRank · unranked

6 citations

Quan‐Zhen Li, Qi Wang, Natalie I. Vokes, Ajay Sheshadri, Jianjun Gao +14 more

Joint multi-omics discriminant analysis with consistent representation learning using PANDA

Research Square(2024)10.21203/rs.3.rs-4353037/v1

N/A

0.217DataRank · unranked

2 citations

Muhammad Aminu, Lingzhi Hong, Natalie I. Vokes, Stephanie Schmidt, Maliazurina B. Saad +15 more

The MEK5–ERK5 Kinase Axis Controls Lipid Metabolism in Small-Cell Lung Cancer

Cancer Research(2020)10.1158/0008-5472.can-19-1027

N/A

0DataRank · unranked

88 citations

Garry L. Coles, Daniel Hornburg, Maya Gershkovitz, Julia Arand, Siqi Cao +11 more

Guanosine triphosphate links MYC-dependent metabolic and ribosome programs in small-cell lung cancer

Journal of Clinical Investigation(2020)10.1172/jci139929

N/A

0DataRank · unranked

76 citations

Kenneth E. Huffman, Zixi Wang, Xun Wang, Kailong Li, Feng Cai +23 more

AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0414

N/A

0DataRank · unranked

55 citations

C. Allison Stewart, Kasey R. Cargill, Carminia Maria Della Corte, Qi Wang, Li Shen +10 more

Association of Medicaid Insurance With Survival Among Patients With Small Cell Lung Cancer

JAMA Network Open(2020)10.1001/jamanetworkopen.2020.3277

N/A

0DataRank · unranked

21 citations

David L. Schwartz, Katherine M.W. Pisters, Abdallah Mohamed, James W. Welsh, Joe Y. Chang +7 more

Metabolic and Functional Genomic Studies Identify Deoxythymidylate Kinase as a Target in LKB1-Mutant Lung Cancer

UNC Libraries(2020)10.17615/ge7q-0q17

N/A

0DataRank · unranked

18 citations

Sean T. Bailey, David J. Kwiatkowski, Pasi A. Jänne, Jeffrey A. Engelman, Julián Carretero +35 more

Evaluation of PARP and PDL-1 as potential therapeutic targets for women with high-grade neuroendocrine carcinomas of the cervix

International Journal of Gynecological Cancer(2020)10.1136/ijgc-2020-001649

N/A

0DataRank · unranked

44 citations

Preetha Ramalingam, Gloria Salvo, Junya Fujimoto, Luisa M. Solis Soto, Natacha Phoolcharoen +5 more

Comparative genomics of high grade neuroendocrine carcinoma of the cervix

PLoS ONE(2020)10.1371/journal.pone.0234505

N/A

0DataRank · unranked

42 citations

Robert J. Cardnell, Junya Fujimoto, Won-Chul Lee, Jianjun Zhang, Lauren A. Byers +6 more

1736P Elevated AXL expression following SARS-CoV-2 infection in non-small cell lung cancer

Annals of Oncology(2020)10.1016/j.annonc.2020.08.1800

N/A

0DataRank · unranked

2 citations

C. Allison Stewart, Carl M. Gay, Robert J. Cardnell, Li Diao, Q. Wang +9 more

Lung cancer models reveal SARS-CoV-2-induced EMT contributes to COVID-19 pathophysiology

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.28.122291

N/A

0DataRank · unranked

38 citations

Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson +23 more

Resolving the spatial and cellular architecture of lung adenocarcinoma by multi-region single-cell sequencing

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.04.283739

N/A

0DataRank · unranked

18 citations

Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick M. Brennan, Minghao Dang +36 more

Single-cell analysis of human lung epithelia reveals concomitant expression of the SARS-CoV-2 receptor ACE2 with multiple virus receptors and scavengers in alveolar type II cells

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.04.16.045617

N/A

0DataRank · unranked

6 citations

Ansam Sinjab, Warapen Treekitkarnmongkol, Patrick M. Brennan, Kieko Hara, Kyle Chang +27 more

1745P SARS-CoV-2 infects metabolically-primed epithelial cells in lung cancer models

Annals of Oncology(2020)10.1016/j.annonc.2020.08.1809

N/A

0DataRank · unranked

0 citations

C. Allison Stewart, Carl M. Gay, Kavya Ramkumar, Robert J. Cardnell, Monique B. Nilsson +13 more

Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.30.180844

N/A

0DataRank · unranked

0 citations

Runzhe Chen, Ying Jin, Jun Li, Jiexin Zhang, Junya Fujimoto +32 more

Multiplatform Analysis of 12 Cancer Types Reveals Molecular Classification within and across Tissues of Origin

UNC Libraries(2020)10.17615/3e2x-wy62

N/A

0DataRank · unranked

0 citations

David A. Wheeler, Zhong Chen, Lynda Chin, Todd Pihl, Tai Hsien Ou Yang +95 more

Patterns of transcription factor programs and immune pathway activation define four major subtypes of SCLC with distinct therapeutic vulnerabilities

Cancer Cell(2021)10.1016/j.ccell.2020.12.014

N/A

0DataRank · unranked

945 citations

C. Allison Stewart, Elizabeth M. Park, Lixia Diao, Sarah M. Groves, Simon Heeke +25 more

Distinct tumor-infiltrating lymphocyte landscapes are associated with clinical outcomes in localized non-small-cell lung cancer

Annals of Oncology(2021)10.1016/j.annonc.2021.09.021

N/A

0DataRank · unranked

137 citations

Daniel J. McGrail, Salah-Eddine Bentebibel, Cara Haymaker, Angelo Ravelli, Marie‐Andrée Forget +31 more

Resolving the Spatial and Cellular Architecture of Lung Adenocarcinoma by Multiregion Single-Cell Sequencing

Cancer Discovery(2021)10.1158/2159-8290.cd-20-1285

N/A

0DataRank · unranked

134 citations

Guangchun Han, Warapen Treekitkarnmongkol, Kieko Hara, Patrick M. Brennan, Minghao Dang +35 more

Th17 cells contribute to combination MEK inhibitor and anti-PD-L1 therapy resistance in KRAS/p53 mutant lung cancers

Nature Communications(2021)10.1038/s41467-021-22875-w

N/A

0DataRank · unranked

70 citations

B. Leticia Rodriguez, Lixia Diao, Pierre-Olivier Gaudreau, Aparna Padhye, Jessica Konen +9 more

Targeting MYC-enhanced glycolysis for the treatment of small cell lung cancer

Cancer & Metabolism(2021)10.1186/s40170-021-00270-9

N/A

0DataRank · unranked

64 citations

C. Allison Stewart, Elizabeth M. Park, Kavya Ramkumar, Carl M. Gay, Robert J. Cardnell +10 more

Lung Cancer Models Reveal Severe Acute Respiratory Syndrome Coronavirus 2–Induced Epithelial-to-Mesenchymal Transition Contributes to Coronavirus Disease 2019 Pathophysiology

Journal of Thoracic Oncology(2021)10.1016/j.jtho.2021.07.002

N/A

0DataRank · unranked

57 citations

Carl M. Gay, Kavya Ramkumar, Kasey R. Cargill, Robert J. Cardnell, Monique B. Nilsson +23 more

Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers

Frontiers in Oncology(2021)10.3389/fonc.2021.757323

N/A

0DataRank · unranked

21 citations

William L. Hasken, Carl M. Gay, Lauren A. Byers, Kasey R. Cargill

Cold and heterogeneous T cell repertoire is associated with copy number aberrations and loss of immune genes in small-cell lung cancer

Nature Communications(2021)10.1038/s41467-021-26821-8

N/A

0DataRank · unranked

52 citations

Runzhe Chen, Ying Jin, Jun Li, Xin Hu, Jiexin Zhang +40 more

SLFN11 biomarker status predicts response to lurbinectedin as a single agent and in combination with ATR inhibition in small cell lung cancer

Translational Lung Cancer Research(2021)10.21037/tlcr-21-437

N/A

0DataRank · unranked

40 citations

Robert J. Cardnell, Bingnan Zhang, Li Shen, C. Allison Stewart, Kavya Ramkumar +5 more

Phase 2 Study of Talazoparib in Patients With Homologous Recombination Repair–Deficient Squamous Cell Lung Cancer: Lung-MAP Substudy S1400G

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.01.001

N/A

0DataRank · unranked

32 citations

Mary W. Redman, Lauren A. Byers, Fred R. Hirsch, Philip C. Mack, Lawrence H. Schwartz +12 more

Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

Cancer Research(2021)10.1158/0008-5472.can-20-1895

N/A

0DataRank · unranked

31 citations

B. Leticia Rodriguez, Aparna Padhye, Joshua K. Ochieng, Laura Gibson, Lixia Diao +9 more

A Dose-finding Study Followed by a Phase II Randomized, Placebo-controlled Trial of Chemoradiotherapy With or Without Veliparib in Stage III Non–small-cell Lung Cancer: SWOG 1206 (8811)

Clinical Lung Cancer(2021)10.1016/j.cllc.2021.02.009

N/A

0DataRank · unranked

26 citations

Jieling Miao, Mihaela Cristea, Allen Chen, Jacob Sands, Roy H. Decker +13 more

Single-Cell Expression Landscape of SARS-CoV-2 Receptor ACE2 and Host Proteases in Normal and Malignant Lung Tissues from Pulmonary Adenocarcinoma Patients

Cancers(2021)10.3390/cancers13061250

N/A

0DataRank · unranked

12 citations

Ansam Sinjab, Kieko Hara, Warapen Treekitkarnmongkol, Patrick M. Brennan, Kyle Chang +26 more

Genomic and TCR Repertoire Intratumor Heterogeneity of Small-cell Lung Cancer and its Impact on Survival

Research Square(2021)10.21203/rs.3.rs-148314/v1

N/A

0DataRank · unranked

0 citations

Runzhe Chen, Ying Jin, Jun Li, Jiexin Zhang, Junya Fujimoto +36 more

Immunogenomic Intertumor Heterogeneity Across Primary and Metastatic Sites in a Patient With Lung Adenocarcinoma

Research Square(2021)10.21203/rs.3.rs-970663/v1

N/A

0DataRank · unranked

0 citations

Jun Li, Junya Fujimoto, Xin Hu, Kelly Quek, Ming Tang +17 more

Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

medRxiv(2021)10.1101/2021.08.01.21260883

N/A

0DataRank · unranked

0 citations

Jun Li, Junya Fujimoto, Xin Hu, Kelly Quek, Ming Tang +17 more

Immunogenomic intertumor heterogeneity across primary and metastatic sites in a patient with lung adenocarcinoma

Journal of Experimental & Clinical Cancer Research(2022)10.1186/s13046-022-02361-x

N/A

0DataRank · unranked

7 citations

Jun Li, Junya Fujimoto, Lingzhi Hong, Xin Hu, Kelly Quek +18 more

SWOG S2012: Randomized phase II/III trial of first line platinum/etoposide (P/E) with or without atezolizumab (NSC#783608) in patients (pts) with poorly differentiated extrapulmonary small cell neuroendocrine carcinomas (NEC).

Journal of Clinical Oncology(2022)10.1200/jco.2022.40.16_suppl.tps4179

N/A

0DataRank · unranked

5 citations

Edward Mayerson, E. Gabriela Chiorean, Earle F. Burgess, Elizabeth M. Swisher, Carl M. Gay +9 more

The impact of targeting TRAF2 and NCK-interacting protein kinase (TNIK) on anti-tumor effect in small cell lung cancer

(2022)10.52519/00089

N/A

0DataRank · unranked

0 citations

Ben Morris, Kavya Ramkumar, Robert J. Cardnell, Li Shen, Qi Wang +5 more

Combining targeted DNA repair inhibition and immune-oncology approaches for enhanced tumor control

Molecular Cell(2023)10.1016/j.molcel.2022.12.031

N/A

0DataRank · unranked

59 citations

Benjamin B. Morris, Carl M. Gay, Lauren A. Byers, Kyle Concannon

Targeting BCL2 Overcomes Resistance and Augments Response to Aurora Kinase B Inhibition by AZD2811 in Small Cell Lung Cancer

Clinical Cancer Research(2023)10.1158/1078-0432.ccr-23-0375

N/A

0DataRank · unranked

28 citations

Azusa Tanimoto, Carminia M. Della Corte, C. Allison Stewart, Qi Wang, Li Shen +12 more

Real-World Efficacy and Safety of Amivantamab for EGFR-Mutant NSCLC

Journal of Thoracic Oncology(2023)10.1016/j.jtho.2023.11.020

N/A

0DataRank · unranked

25 citations

Robyn Du, Nathaniel J. Myall, Whitney E. Lewis, Natalie Uy, Lingzhi Hong +22 more

BRAF v600E–mutant cancers treated with vemurafenib alone or in combination with everolimus, sorafenib, or crizotinib or with paclitaxel and carboplatin (VEM-PLUS) study

npj Precision Oncology(2023)10.1038/s41698-022-00341-0

N/A

0DataRank · unranked

22 citations

Jason Roszik, Filip Jankú, David S. Hong, Shumei Kato, Aung Naing +11 more

Brief Report: Comprehensive Clinicogenomic Profiling of Small Cell Transformation From EGFR-Mutant NSCLC Informs Potential Therapeutic Targets

JTO Clinical and Research Reports(2023)10.1016/j.jtocrr.2023.100623

N/A

0DataRank · unranked

11 citations

Whitney E. Lewis, C. Allison Stewart, Benjamin B. Morris, Luisa M. Solis, Alejandra G. Serrano +31 more

Unfolding the secrets of small cell lung cancer progression: Novel approaches and insights through rapid autopsies

Cancer Cell(2023)10.1016/j.ccell.2023.08.007

N/A

0DataRank · unranked

8 citations

Simon Heeke, Benjamin J. Drapkin, Anna Solta, Ildikó Kovács, Kristiina Boettiger +16 more

YAP1 status defines two intrinsic subtypes of LCNEC with distinct molecular features and therapeutic vulnerabilities

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.12.19.572449

N/A

0DataRank · unranked

1 citations

Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar, Alejandra G. Serrano +23 more

Data from Dual Inhibition of MEK and AXL Targets Tumor Cell Heterogeneity and Prevents Resistant Outgrowth Mediated by the Epithelial-to-Mesenchymal Transition in NSCLC

(2023)10.1158/0008-5472.c.6512518.v1

N/A

0DataRank · unranked

0 citations

B. Leticia Rodriguez, Aparna Padhye, Joshua K. Ochieng, Laura F. Gibson, Lixia Diao +9 more

Data from AXL Inhibition Induces DNA Damage and Replication Stress in Non–Small Cell Lung Cancer Cells and Promotes Sensitivity to ATR Inhibitors

(2023)10.1158/1541-7786.c.6545156.v1

N/A

0DataRank · unranked

0 citations

C. Allison Stewart, Kasey R. Cargill, Carminia Maria Della Corte, Qi Wang, Li Shen +10 more

Analysis of tumor- and circulating-free DNA methylation to identify clinically relevant small cell lung cancer subtypes.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.16_suppl.8577

N/A

0DataRank · unranked

0 citations

Carl M. Gay, Marcos R. Estecio, Hai T. Tran, Benjamin B. Morris, Bingnan Zhang +15 more

CTLA4 blockade abrogates KEAP1/STK11-related resistance to PD-(L)1 inhibitors

Nature(2024)10.1038/s41586-024-07943-7

N/A

0DataRank · unranked

165 citations

Haniel A. Araújo, Minh Truong, Yu Qian, Xin Sun, Ana Galán‐Cobo +95 more

Tumor- and circulating-free DNA methylation identifies clinically relevant small cell lung cancer subtypes

Cancer Cell(2024)10.1016/j.ccell.2024.01.001

N/A

0DataRank · unranked

116 citations

Carl M. Gay, Marcos R. Estecio, Hai T. Tran, Benjamin B. Morris, Bingnan Zhang +37 more

Phase II Randomized Study of Maintenance Atezolizumab Versus Atezolizumab Plus Talazoparib in Patients With SLFN11 Positive Extensive-Stage SCLC: S1929

Journal of Thoracic Oncology(2024)10.1016/j.jtho.2024.10.021

N/A

0DataRank · unranked

32 citations

Jieling Miao, Karen L. Reckamp, Carl M. Gay, Lauren A. Byers, Ying‐Qi Zhao +15 more

Antitumor Activity and Biomarker Analysis for TROP2 Antibody–Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-1948

N/A

0DataRank · unranked

22 citations

Erkan Yuca, Kurt W. Evans, Ming Zhao, Takanori Maejima, Tsuyoshi Karibe +12 more

YAP1 Status Defines Two Intrinsic Subtypes of LCNEC with Distinct Molecular Features and Therapeutic Vulnerabilities

Clinical Cancer Research(2024)10.1158/1078-0432.ccr-24-0361

N/A

0DataRank · unranked

14 citations

Lixia Diao, Yuanxin Xi, Runsheng Wang, Kavya Ramkumar, Alejandra G. Serrano +24 more

Tumour-intrinsic PDL1 signals regulate the Chk2 DNA damage response in cancer cells and mediate resistance to Chk1 inhibitors

Molecular Cancer(2024)10.1186/s12943-024-02147-z

N/A

0DataRank · unranked

11 citations

Anand Kornepati, Carlos Ontiveros, Yiji Liao, Bárbara de la Peña Avalos, Cody M. Rogers +25 more

Impact of psychosocial factors on the success of neuromodulation treatment for patients with persistent pain

Regional Anesthesia & Pain Medicine(2024)10.1136/rapm-2023-104962

N/A

0DataRank · unranked

9 citations

Nalin Payakachat, Lauren A. Byers, Gregory L. Smith, Jarna R Shah, Kimberly Stephens +1 more

CoCo-ST: Comparing and Contrasting Spatial Transcriptomics data sets using graph contrastive learning

Research Square(2024)10.21203/rs.3.rs-4359834/v1

N/A

0DataRank · unranked

0 citations

Muhammad Aminu, Bo Zhu, Natalie I. Vokes, Hong Chen, Lingzhi Hong +18 more

Rapid Intracranial Response With Tarlatamab in Patients With Untreated Brain Metastases From SCLC—A Real-World Case Series: Case Report

Journal of Thoracic Oncology(2025)10.1016/j.jtho.2025.02.023

N/A

0DataRank · unranked

17 citations

Komal Shah, Mitchell Parma, Kaiwen Wang, Eric K. Singhi, Whitney E. Lewis +23 more

DNA-PK inhibition sustains the antitumor innate immune response in small cell lung cancer

iScience(2025)10.1016/j.isci.2025.111943

N/A

0DataRank · unranked

6 citations

Floriana Morgillo, Luisa Amato, Francesca Iommelli, Viviana De Rosa, Virginia Tirino +23 more

YAP1 defines an emergent, plastic population of relapsed small cell lung cancer

bioRxiv (Cold Spring Harbor Laboratory)(2025)10.1101/2025.10.21.683746

N/A

0DataRank · unranked

0 citations

Kavya Ramkumar, Runsheng Wang, Yuanxin Xi, Alexa Halliday, Lixia Diao +19 more

Programmed Death-Ligand 1 Heterogeneity and Its Impact on Benefit From Immune Checkpoint Inhibitors in NSCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.04.026

N/A

0DataRank · unranked

194 citations

Marcelo V. Negrão, Seyedeh Dibaj, Runzhe Chen, Alexandre Reuben, Jadi M. Bohac +32 more

Development of PET/CT-clinical nomograms for predicting lymph node metastasis in primary lung cancer

European Radiology(2025)10.1007/s00330-025-12166-z

N/A

0DataRank · unranked

0 citations

Wentao Li, Julie Lin, Shuoyang Li, Maliazurina B. Saad, Yuliya Kitsel +17 more

New Approaches to SCLC Therapy: From the Laboratory to the Clinic

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.01.016

N/A

0DataRank · unranked

177 citations

Julie George, Taofeek K. Owonikoko, Anton Berns, Élisabeth Brambilla, Lauren A. Byers +42 more

Collagen promotes anti-PD-1/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion

Nature Communications(2020)10.1038/s41467-020-18298-8

N/A

0DataRank · unranked

451 citations

B. Leticia Rodriguez, Lixia Diao, Limo Chen, Jing Wang, Lauren A. Byers +11 more

Characterization of the Immune Landscape of EGFR-Mutant NSCLC Identifies CD73/Adenosine Pathway as a Potential Therapeutic Target

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.12.010

N/A

0DataRank · unranked

126 citations

Marcelo V. Negrão, Alexandre Reuben, Lorenzo Federico, Lixia Diao, Daniel J. McGrail +34 more

Phase 1/2 Trial of Pembrolizumab and Concurrent Chemoradiation Therapy for Limited-Stage SCLC

Journal of Thoracic Oncology(2020)10.1016/j.jtho.2020.08.022

N/A

0DataRank · unranked

98 citations

John V. Heymach, Chunxiao Guo, Hari Menon, Katherine Klein, Taylor R. Cushman +19 more

NOTCH1 Signaling in Head and Neck Squamous Cell Carcinoma

Cells(2020)10.3390/cells9122677

N/A

0DataRank · unranked

90 citations

Chenfei Huang, Qiuli Li, Sawad A. Kazi, Lauren A. Byers, Jing Wang +3 more